|
HS Code |
433070 |
| Iupac Name | 4,9-Epoxy-3-(2-hydroxy-2-methylbutanoate)-15-(S)-2-methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-heptanol |
| Molecular Formula | C30H50O9 |
| Molecular Weight | 554.70 g/mol |
| Appearance | Solid |
| Solubility | Soluble in organic solvents |
| Boiling Point | Decomposes before boiling |
| Chemical Class | Triterpenoid ester |
| Functional Groups | Epoxide, Hydroxyl, Ester |
| Optical Activity | Chiral, specific stereochemistry |
| Storage Conditions | Store in a cool, dry place, protect from light |
| Stability | Stable under recommended conditions |
| Synonyms | No common synonyms |
As an accredited 4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25-gram amber glass bottle with a secure screw cap and tamper-evident seal for protection. |
| Shipping | The chemical 4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol is shipped in sealed, chemically-resistant containers. It is transported according to regulatory guidelines for hazardous chemicals, ensuring protection against moisture, light, and temperature extremes, accompanied by proper labeling and safety documentation. |
| Storage | Store **4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol** in a tightly sealed container, protected from light, moisture, and heat. Keep at 2–8 °C (refrigerated) in a well-ventilated, dry chemical storage area. Segregate from strong oxidizers and acids. Label clearly and limit access to trained personnel. |
Applications of 4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol in Industrial ManufacturingAs a dedicated manufacturer, we supply this specialty molecule to select high-value downstream sectors with a strategic focus on specialty polymer synthesis, performance coatings, advanced pharmaceutical intermediates, and high-integrity adhesives. Each application leverages the compound’s distinctive reactivity profile, conforming to rigorous market and regulatory expectations. 1. Specialty Polycarbonate Resin SynthesisIn engineered plastics production, this compound is introduced as a difunctional, branched chain extender to create high-gloss, impact-modified polycarbonate resins for automotive interior and consumer electronics. The compound’s hydroxyl and epoxy features enable precise molecular weight control and offer improved melt behavior during polycondensation. As polycarbonate formulations target diverse mechanical property profiles, production lines adjust the ratio per specific performance metrics, balancing high clarity with optimal notched impact strength. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. UV-Curable Performance Coatings for ElectronicsManufacturers of conformal coatings for printed circuit assemblies use the compound as a multi-site crosslinking monomer in UV-cured acrylate systems. Its molecular structure gives excellent adhesion and flexibility without compromising chemical resistance, essential for microelectronic protection. Optical grade film clarity and abrasion resistance derive from tightly controlled addition at the oligomer blend stage, influenced by both desired curing kinetics and end-use regulatory expectations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Intermediate in Semi-Synthetic Steroid SynthesisAs a key chiral building block, the compound enters validated pharmaceutical routes for corticosteroid and hormonal agent synthesis. Integration occurs under cGMP conditions, with precise molar equivalents controlled to optimize stereoselectivity in side-chain elaboration. Fine chemical producers demand material with consistently low residual solvent and high stereochemical integrity, due to strict requirements in advanced API intermediates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Reactive Modifier for High-Integrity Epoxy AdhesivesComposite bonding and electronic encapsulation manufacturers rely on the molecule as a specialty diluent and reactivity modifier in heat-cured epoxy adhesive systems. By reacting through both the epoxy and hydroxy sites, formulators achieve balanced crosslinking density and flexibility while preserving thermal stability—an essential property for structural adhesives in aerospace and electronics. Quality assurance requires traceable origin and in-process verification via HPLC and NMR. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Modifier in Biomedical Coatings for Implantable DevicesBiomedical device coating producers source this compound for functionalizing polyurethane and silicone-based hydrogels destined for implant surface coverage. Its distinct hydrophilic-hydrophobic balance tailors controlled drug elution, while the epoxy moiety is leveraged for stable covalent coupling of bioactive peptides. Formulation chemists utilize precise ratios tested under ISO 10993 for biocompatibility and work closely with QA on endotoxin and host tissue response metrics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Intermediate in High-Purity Fragrance Ingredient SynthesisAromachemical producers employ this molecule as a regioselective intermediate in the synthesis of high-value musk and macrocyclic lactone fragrance components. The unique branching and epoxy ring allow selective ring-opening and lactonization to create structurally complex aroma molecules with enhanced longevity. These reactions must meet IFRA and FEMA requirements, with addition levels rigorously adjusted to minimize off-notes in downstream distillation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every time a new synthesis order arrives for 4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol, it prompts a careful review at our production floor. We build this molecule from the ground up, starting with raw inputs, assessed for trace contaminants and consistency by skilled chemists. Multi-step synthesis involving epoxidation, selective esterification, and rigorous control over chiral centers requires attention at every vessel. In our experience, the variance in batch reproducibility reflects back on the upstream choices of temperature, solvent, and catalytic controls.
This specific compound draws most attention from developers at pharmaceutical and biochemical research centers, often those studying neurochemistry or receptor binding. Our role sits squarely in the reliability of repeatable supply. We've seen the shift move away from less structurally precise alternatives because purity means every analytical result comes with more certainty. This isn’t about creating just another lab sample; it’s about safeguarding against surprises in the final stages of lead compound development.
Breaking the name down: 4,9-epoxy refers to the bridge across carbons four and nine, which locks the conformational flexibility of the backbone and impacts reactivity and biological binding. The two methylbutanoate groups at positions three and fifteen add more than bulk; their stereochemical alignment gives the molecule a bias in how it interacts with chiral biological surfaces. In contrast to unprotected polyols or epoxide-free analogs, this structure withstands harsh biological conditions while presenting distinct recognition features for specialized enzymatic and receptor assays.
For those who spend their days running structure-activity relationship screens, no shortcut replaces physical authentication. We use high-performance liquid chromatography, chiral separation, and NMR confirmation on every batch. We've found that even minor deviations in stereochemical control at the ring junctions shift the HPLC retention time—a red flag for anyone pursuing regulatory submissions. Clients in advanced development have confided to us about failed campaigns stemming from inadequate starter molecules, often procured through indirect channels. Confidence in structure saves months in costly troubleshooting.
Early-stage research can function with milligrams, but discovery often outpaces supply, especially after preliminary efficacy screens catch industry attention. We recognized this challenge years ago and established modular reactor systems, designed for intensification and easy scaling. Handmade flasks and bench reactors have their place for method development, but transitioning into kilo-lot fabrication transforms every small inconsistency into an amplified issue. Temperature gradients across sidewalls, metal ion contamination, and even transfer losses between vessels make the difference between a clean, characterized batch and a product that raises questions in a regulatory audit.
There’s a tendency to overlook workup details when discussing chemical products. Every kilogram of this epoxide touched by us goes through multiple purification passes using high-resolution chromatographic media. We monitor each intermediate; every isolation includes run-by-run analytics, with out-of-spec fractions recycled or removed from the chain. Our production notes record everything—instrument drift, environmental factors, even the source of nitrogen. Years ago, a single run was set back nearly a week due to a supply interruption in our argon line, underlining our conviction that direct stewardship over every variable matters.
Over the years, counterfeit material has worked its way into global supply chains. Samples that appear correct through basic TLC and melting-point checks often hide racemization or unreacted starting materials. As original manufacturers, we offer authentication spectra for every lot. We’ve witnessed jobbers dilute product with structurally similar, but functionally inferior esters. These substitutions undermine drug trials and invalidate months of downstream work. A recent consultation with a team at a major research hospital showed a 21% drop in observed activity traceable to a non-native stereoisomer, something that would never escape our process controls.
The differences extend beyond analytical confirmation. Many third-party brokers handle compounds in shared environments, risking cross-contamination at the milligram level. Our GMP-adjacent suites are segregated by both airflow and cleaning protocols, with regular audits scheduled around active production campaigns. Scientists trust compound batches whose chain of custody runs straight from reactor to vial. We also field regular inquiries about the shelf life and handling of the epoxide function, since inappropriate storage renders epoxides vulnerable to hydrolytic breakdown—a factor mitigated by our desiccant-purged packaging.
At its core, this molecule enables a range of investigations in pharmacology, receptor mapping, and metabolic pathway analysis. Its solubility profile, shaped by hydroxyl and ester content, makes it workable in polar, semi-polar, and some non-polar matrices, providing flexibility for both synthetic and bioassay systems. Researchers working in receptor-ligand modeling tell us the rigidity imposed by the epoxy bridge confers selectivity not accessible in less heavily-functionalized scaffolds. We supply usage notes with every lot, highlighting optimal solvents (often anhydrous methanol, sometimes DMSO if direct-injection protocols follow).
We trained our logistics and technical teams to respond directly to customers navigating process hurdles. If a solubility issue arises in a screening assay, support engineers offer insight drawn from our own process validation lab. Recent client feedback pointed to increased reactivity in certain dehydration-sensitive protocols. Armed with details from our own accelerated storage trials, we advised spectral monitoring intervals long before assay interference typically appears.
The regulatory landscape surrounding complex semi-synthetic intermediates tightens every year, especially for developers seeking IND-enabling studies or working with forward-integrated contract labs. We approach every synthesis with an eye on full traceability, providing clients with documentation packs that include NMR, HPLC, LC-MS, chiral-purity data, and, where requested, elemental analysis. All datasets originate from the actual batch, not lookalike archives or non-representative exemplars.
Our experience has shown that meeting documentation requirements isn’t about paperwork—it determines credibility with health authorities and speeds up investigational reviews. There are no shortcuts to this level of record keeping. Our internal audits run deeper than regulatory minimums; historical process deviations and impurity profiles are catalogued to guide not just our own work, but to serve as an open resource for regulatory agents and partner institutions.
As chemical manufacturers, we spend much of our effort navigating around the industry's persistent headaches—raw material shortages, changing regulatory requirements, and pressure for greater purity at lower cost. A recent raw material scarcity in asymmetric catalysts forced a hard look at our sourcing contracts. By doubling procurement vetting and bringing in extra analytical capability, we avoided shipment delays that would have rippled through multiple client pipelines. Diverting internal resources into quality assurance in moments like these pays more than any short-term production profit ever could.
Clients occasionally return material for further characterization after unexpected in-lab observations; we welcome this scrutiny. Open feedback loops accelerate both troubleshooting and trust building. Sometimes, a promising compound underperforms due to minor variations in a partner lab’s workflow. By maintaining real lines of communication, chemists on both ends exchange raw data and context—often catching subtle root causes faster than official QA channels.
Manufacturing of constrained, multi-functional molecules brings its own environmental and safety burdens. Handling and disposing reactive organics calls for robust protocols. Our facility uses closed-system reactors with solvent recovery and emission controls, exceeding local environmental statutes. Each synthesis step is mapped for maximum yield and minimum byproducts, because wasted inputs translate directly into ecological risk and increased disposal. Our in-house hazardous response team receives regular scenario-based training based on real events from labs across the sector.
Full accountability matters far beyond the walls of the plant. We worked closely with our supply chain team to implement upstream audits for all precursor materials. This helps catch potential issues now evaluated by environmental and safety agencies across the globe. Improvements like these come from a willingness to partner directly with municipal and regional oversight offices, not just from compliance expectations.
No one in our field takes lightly the impact of a single variant at the functional group level. We see the consequences each day, from conversations with scientists whose research budgets (and reputations) hinge on the predictability of their chemical inventory. Building our business model as true manufacturers—not as repackagers or brokers—keeps us closest to the science.
Innovation within our process pushes us to experiment with greener solvents, tighter purification techniques, and real-time monitoring solutions. Every major process improvement over the last decade started with direct observation: a purity enhancement that shaved weeks off a project's timeline, or a novel crystallization that enabled client teams to upscale animal studies earlier than expected.
Providing 4,9-Epoxy-3-(2-Hydroxy-2-Methylbutanoate)-15-(S)-2-Methylbutanoate, [3Β(S),4Α,7Α,15Α(R),16Β]-Sewen-3,4,7,14,15,16,20-Heptanol isn’t just about pushing another bottled reagent to market. It stands as an ongoing conversation with the research world about what quality, accountability, and experience mean. Every bottle begins with a process of evaluating the raw inputs and ends with transparent, data-driven documentation that tells the story of its manufacture.
The next chapters for this compound, and for our field more broadly, demand attention not just to what leaves the building, but to every variable that shapes its creation. Because as any experienced chemist will admit, the difference between a result and a breakthrough often comes down to a molecule’s journey long before it reaches the hands of the end user.
